Dose adjustments may be made to keep IGF-1 within an appropriate target range for age
Therapeutic Potential of CKD-506, a Novel Selective Histone Deacetylase 6 Inhibitor, in a Murine Model of Rheumatoid Arthritis
This guide is for personal use only
I explain to my patients that (like in any disease) our bodies will decide that our reproductive hormones are not a priority when we are ill
Age & Hormonal Health : Older individuals or those with a significant GH deficiency may notice more dramatic improvements compared to younger, healthier individuals
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy